Accumulation of fluid in peritoneal cavity i.e., the space between lining of abdomen and abdominal organs, is referred as ascites. Liver cirrhosis is one of the common case of ascites. Presence of ascites is a sign of significant portal hypertension. High pressure in blood vessels of liver and low levels of albumin (protein) results in ascites. Additionally, less common factors such as kidney failure, heart failure, infection in pancreas, and cancers could contribute to ascites development. Moreover, hypothyroidism, nephritic syndrome, and ovarian diseases in females are conditions that could lead to ascites. Vomiting, heartburn, abdominal pain, nausea, lack of appetite, shortness of breath, and distended abdomen are common symptoms of ascites. Magnetic resonance imaging (MRI) scan, laparoscopy, computed tomography, and angiography are the methods used to diagnose ascites. Ultrasound tests and urinanalysis are also performed for ascites.
Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=55797
Rise in prevalence of liver cirrhosis is anticipated to drive the global ascites market. Additionally, surge in the number of patients suffering from liver cirrhosis due to increase in alcohol consumption is expected to drive the global market. Rise in cases of cancer and improvement in reimbursement also boost the growth of the global market. However, complications associated with ascites treatment is one of the factors likely to restrain the global ascites market.
Request for Analysis of COVID19 Impact on Ascites Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=55797
The global ascites market can be segmented based on type, diagnosis, treatment, and end-user. In terms of type, the market can be bifurcated into exudate ascites and transudative ascites. Based on diagnosis, the global ascites market can be divided into angiography, ultrasound, laparoscopy, CT scan, and others. The ultrasound segment is projected to grow at a rapid pace during the forecast period. Based on treatment, the market can be classified into medicinal therapy, paracentesis, liver transplantation, and others. The medicinal therapy segment can be categorized into diuretics and antibiotics. In terms of end-user, the global ascites market can be segmented into hospitals, clinics, ambulatory surgical centers, diagnostics centers, and others.
Pre book Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=55797<ype=S
The global ascites market can be segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global market in 2017 due to high health care expenditure, developed technologies, rise in prevalence of cirrhosis, and presence of leading players in the region. Increase in awareness about ascites diagnostic test and related treatments is anticipated to drive the market in Europe. Additionally, skilled health care professionals, rise in alcohol consumption, and obesity are the factors to expected to propel the ascites market in the region during the forecast period. Moreover, rise in prevalence of liver cirrhosis and increase in number of surgeries are projected to augment the ascites market in the region. Asia Pacific is anticipated to be the fastest growing market for ascites treatment due to surge in awareness about ascites and related treatment, rapidly developing health care infrastructure, and increase in literacy rate. Poor economy and inadequate health care infrastructure are expected to hamper the growth of the ascites market in Middle East & Africa.
Ask for Discount:
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=55797
The global ascites market is highly fragmented due to the presence of large number of global and local players. Focus on innovative treatment options is expected to drive the global market during the forecast period. Key players operating in the global market are Sofinnova, PharmaCyte, Biotech Inc., Sequana Medical NV, BioVie, Inc., Becton, Dickinson and Company, Medtronic plc, GI Supply, QED Bioscience, Inc., Fresenius SE & Co. KGaA, and Abcore, Inc.
Browse More Trending Reports by Transparency Market Research:
Fetal Bovine Serum Market:
Blood Glucose Monitoring Systems Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
